Target intelligence / Profile preview

Keratin 16 pseudogene 3 (KRT16P3)

Target
KRT16P3
Molecular classification
Pseudogene, Other
01

Overview

Keratin 16 pseudogene 3 (KRT16P3), also known as MGC102966, is classified as a pseudogene and not a protein-coding gene. It is related to the functional Keratin 16 gene (KRT16), which encodes an intermediate filament protein involved in the structural integrity of epithelial cells, particularly in skin, hair, and nails. However, KRT16P3 itself does not code for a functional protein, and there is no evidence that it is involved in any biological function, disease association, or serves as a therapeutic target[5][7][9][12].

Other names
MGC102966KERSMCR

Beyond the preview

Go deeper on Keratin 16 pseudogene 3 (KRT16P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin 16 pseudogene 3 (KRT16P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call